Invex Therapeutics (Australia) Probability of Future Stock Price Finishing Over 3.75
| IXC Stock | 0.07 0 2.86% |
Invex |
Invex Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Invex Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Invex Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Invex Therapeutics generated a negative expected return over the last 90 days | |
| Invex Therapeutics has some characteristics of a very speculative penny stock | |
| Invex Therapeutics has high historical volatility and very poor performance | |
| The company reported the revenue of 1.21 M. Net Loss for the year was (1.64 M) with profit before overhead, payroll, taxes, and interest of 1.21 M. | |
| Invex Therapeutics generates negative cash flow from operations | |
| About 68.0% of the company shares are held by company insiders |
Invex Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Invex Stock often depends not only on the future outlook of the current and potential Invex Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Invex Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 75.3 M | |
| Cash And Short Term Investments | 6 M |
Invex Therapeutics Technical Analysis
Invex Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Invex Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Invex Therapeutics. In general, you should focus on analyzing Invex Stock price patterns and their correlations with different microeconomic environments and drivers.
Invex Therapeutics Predictive Forecast Models
Invex Therapeutics' time-series forecasting models is one of many Invex Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Invex Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Invex Therapeutics
Checking the ongoing alerts about Invex Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Invex Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Invex Therapeutics generated a negative expected return over the last 90 days | |
| Invex Therapeutics has some characteristics of a very speculative penny stock | |
| Invex Therapeutics has high historical volatility and very poor performance | |
| The company reported the revenue of 1.21 M. Net Loss for the year was (1.64 M) with profit before overhead, payroll, taxes, and interest of 1.21 M. | |
| Invex Therapeutics generates negative cash flow from operations | |
| About 68.0% of the company shares are held by company insiders |
Additional Tools for Invex Stock Analysis
When running Invex Therapeutics' price analysis, check to measure Invex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Invex Therapeutics is operating at the current time. Most of Invex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Invex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Invex Therapeutics' price. Additionally, you may evaluate how the addition of Invex Therapeutics to your portfolios can decrease your overall portfolio volatility.